Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Doxorubicin

Known as: Hydroxyldaunorubicin, 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-, Doxorubicin [Chemical/Ingredient] 
An anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the… Expand
National Institutes of Health

Related topics

Related topics

48 relations
AC-T RegimenCDE protocol-cyclophosphamide/doxorubicin/etoposideCHVmP-VB protocolCOPP-ABV Regimen
Expand

Narrower (20)

ACP protocolCHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristineCISCA protocolDOXO-cell
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Oxidative stress injury in doxorubicin-induced cardiotoxicity.
Doxorubicin (DOX) is widely used as a broad-spectrum anti-tumor anthracycline to treat various cancers. The serious adverse… Expand
Review
2019
Review
2019
Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis.
BACKGROUND & AIMS We performed a systematic review and meta-analysis to comprehensively estimate adenoma miss rate (AMR) and… Expand
Review
2019
Review
2019
MicroRNA Shuttle from Cell-To-Cell by Exosomes and Its Impact in Cancer
The identification of exosomes, their link to multivesicular bodies and their potential role as a messenger vehicle between… Expand
  • table 1
  • table 1
Review
2019
Review
2019
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial
Summary Background Biologically distinct subtypes of diffuse large B-cell lymphoma can be identified using gene-expression… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Review
2019
Review
2019
DNA Nanotechnology-Enabled Drug Delivery Systems.
Over the past decade, we have seen rapid advances in applying nanotechnology in biomedical areas including bioimaging… Expand
Review
2019
Review
2019
Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
Tumor formation and growth depend on various biological metabolism processes that are distinctly different with normal tissues… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2019
Review
2019
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.
PURPOSE Nivolumab, an anti-programmed death-1 monoclonal antibody, has demonstrated frequent and durable responses in relapsed… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Review
2019
Review
2019
Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles
Abstract Considerable development in the application of injectable drug delivery systems for cancer therapy has occurred in the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2018
Review
2018
Deep Learning Localizes and Identifies Polyps in Real Time With 96% Accuracy in Screening Colonoscopy.
BACKGROUND & AIMS The benefit of colonoscopy for colorectal cancer prevention depends on the adenoma detection rate (ADR). The… Expand
Review
2018
Review
2018
Compared Abilities of Endoscopic Techniques to Increase Colon Adenoma Detection Rates: A Network Meta-analysis.
BACKGROUND AND AIMS Adenoma detection rate (ADR) is a quality metric for colorectal cancer screening. We performed a systematic… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE